Merck KGaA (ETR:MRK – Get Free Report) rose 1.5% during mid-day trading on Wednesday . The company traded as high as €135.65 and last traded at €135.00. Approximately 409,351 shares changed hands during trading, The stock had previously closed at €133.00.
Merck KGaA Price Performance
The company has a 50-day moving average of €123.54 and a 200-day moving average of €121.01. The company has a debt-to-equity ratio of 40.47, a quick ratio of 0.72 and a current ratio of 1.51. The stock has a market cap of $60.12 billion, a price-to-earnings ratio of 22.18, a PEG ratio of 2.37 and a beta of 0.81.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Featured Articles
- Five stocks we like better than Merck KGaA
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
